Compare Citigroup Inc. (C) vs Inovio Pharmaceuticals Inc (INO) Price & Performance

Citigroup Inc.Trade

Inovio Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Citigroup Inc. vs Inovio Pharmaceuticals Inc — how do they compare? Citigroup Inc. trades at $135.74 (market cap $226.82B), while Inovio Pharmaceuticals Inc trades at $0.77 (market cap $76.09M). The key difference: Citigroup Inc. is far larger — about 2980.9× Inovio Pharmaceuticals Inc's market cap, and Citigroup Inc. pays a 1.98% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

	C	INO
Market Cap	$226.82B	$76.09M
Sector	Financials	Health
52-Week High	$145.67	$2.87
52-Week Low	$92.59	$0.66
Dividend Yield	1.98%	—
Enterprise Value	—	$47.10M

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

5 key checks before applying for a balance transfer credit card to save on interest and feesFool - Investing News · 4 days agoNeutral Paying a 3% balance transfer fee can save thousands by avoiding high credit card interest rates.Fool - Investing News · 5 days agoBullish View details →

INO

View details →

About Citigroup Inc.

Citigroup Inc. is a diversified financial services holding company that provides a broad range of financial services to consumer and corporate customers. The Company services include investment banking, retail brokerage, corporate banking, and cash management products and services. Citigroup serves customers globally.

About Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.